Clinical Trial: A Pilot Study on the Efficacy and Safety of a Novel Synbiotic Formula (SGR11) in Patients With Inflammatory Bowel Disease (IBD)

U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07411131) titled 'A Pilot Study on the Efficacy and Safety of a Novel Synbiotic Formula (SGR11) in Patients With Inflammatory Bowel Disease (IBD)' on Feb. 09.

Brief Summary: The goal of this clinical trial is to find out whether a synbiotic formula (SGR11) can improve symptoms and health measures in people with inflammatory bowel disease (IBD). The main questions it aims to answer are:

* Does SGR11 lead to overall improvement in a participant's condition after 8 weeks, as measured by the Clinical Global Impression-Improvement Scale (CGI I)?

* Is SGR11 safe and well tolerated in people with IBD?

Participants will:

* Take the study synbiotic formul...